2_SAGE_Appendicies_Background_final

More documents

Recommendations

Info

people do? your children? return to the healthcarefacility?Me or my child neverexperienced severeadverse reactionsfollowingimmunization.experience an AEFI andDo you consider somevaccine productspreventing a disease(influenza-LAIV orstandard/ measles (Monly or MMR) saferthan others?Before administeringthe vaccine, my healthcare worker (HCW)always provided mewith enoughinformation on theside-effects that mightfollow.I consider rotavirusvaccine/ HPV vaccine/meningococcal vaccine/pentavalent vaccine tobe safe.Do you feel your childto be at risk of diarrhea/cervical cancer? Do youthink a vaccine isneeded to preventthese diseases?New vaccines are nottrialed to the samerigorous standard asany normally prescribeddrug?Have you ever delayedvaccinating your childwith a newlyintroduced/recommended vaccine?Why?References: Please see p. 105Do you fear the pain/to you/your child orfear the needles whenreceiving a vaccinemake you hesitate beto immunized?Has pain followingimmunization evermade you reconsiderto have yourself/ yourchild vaccinated?Would you be willing toaccept more vaccinesfor yourself/ your childif there was no paininvolved?Do you trust your HCWto safely administer thevaccine to you/ yourchild?Would you ratherreceive a vaccine asconveniently aspossible or with asmuch medicalconsultation aspossible? Why?What would you preferfor yourself/your child:Receive a vaccine atyour health center/from your doctor orfrom door-to-doorvaccinators/ duringmass vaccinationcampaigns/ schoolbasedprograms? Why?Would you let yourchild get vaccinatedwithin a school-basedimmunizationprogram? If yes, whatare the advantages?Did you ever refrainfrom having yourself/your child vaccinatedduring a massimmunizationcampaign? Why?Did you ever notreturn to a healthcenter/ your doctorafter not receiving thevaccine during aninitial visit? What werethe reasons why youdid not receive thevaccine initially?Have you ever beensent home from thehealth center/ doctor’soffice due to lack ofvaccine? If so, did yougo again to try andreceive it?At your health center,did you ever notreceive a vaccine asthe HCW indicatedthere were too fewpeople to startvaccinating?Did you ever decideagainst a vaccine as itwas produced by amanufacturer you didnot trust? Do youbelieve vaccines madein Europe or Americaare safer than thosemade in middleincome countries?How sure are you thatfollowing therecommended shotschedule is a good ideafor your child?If you had anotherinfant today, wouldyou want him/her toget all therecommended shots?Children get moreshots than are goodfor them.It is better for childrento get fewer vaccinesat the same time.Which medication doyou consider moreeffective- the free-ofchargedrugs providedat your health carecenter/doctor/ by yourgovernment or theones you need to payfor yourself? Why?Do you consider allimportant vaccinesprovided/ covered byyour health insurance/health care plan/health care provider?Would you pay foradditional vaccinesyourself?I wouldn’t mind takingtime off from work tomake sure my childgets vaccinated?Would you be willing topay for a vaccineprivately? If so, forwhich ones?Did you choose yourdoctors based on theirwillingness to alter ordelay the vaccinationschedule according toyour requests?Has your healthcareprovider ever advisedyou that a certainvaccine was notnecessary or had toomany side effects?Which one?Was your doctor everreluctant to administera vaccine you wantedfor yourself/ yourchild? Which vaccineand why?Do you trust the doorto-doorvaccinators?57
Appendix A5.4 WHO EUR Tailoring Immunization Program (TIP)The TIP framework can be accessed:http://www.euro.who.int/The-Guide-to-Tailoring-Immunization-Programmes-TIP.pdfAppendix A5.4.1:Principles for TIPPSI Delta Marketing Planning Process 7 Steps ; Principles of TIP1. The Situation Analysis analyzes the context in which the intervention operates in order toensure selection of the most appropriate target group and behavior, and identify strategicpriorities for the marketing plan.2. Audience Insight means getting to know the target group as a real person – one with a faceand a name – and one with aspirations and desires, not just as a bunch of demographics.Creating such profiles is a technique that has been used successfully by commercial sectorgiants such as Proctor and Gamble.3. Brand Positioning is the identification and promotion of the most important and uniquebenefit that the product/ service/ behavior stands for in the mind of the target group. This isthe emotional “hook” upon which one can hang the marketing strategy.4. Marketing Objectives specify what you want to achieve during the marketing plan, ensuringit stays focused and true to the evidence. This also facilitates easier monitoring ofintervention progress.5. The Four Marketing “P’s” – Product, Price, Place and Promotion -- specify what strategiesone will use to achieve the marketing objectives.6. The Research Plan details how the intervention will monitor and evaluate implementation ofthe plan, as well as identifying and prioritizing any information gaps about the target groupand how they will be explored.7. An integrated Budget and Work Plan specify how financial resources will be allocated amongthe 4Ps and help managers allocate human and other resources as well as monitorimplementation.58
Page 1:
APPENDICES TO THEREPORT OF THE SAGE
Page 4 and 5:
vaccine hesitancy in low income cou
Page 6 and 7:
INDIVIDUAL andGROUPINFLUENCESInflue
Page 8 and 9: Another model reviewed by the Worki
Page 10 and 11: Appendix for Section 4Appendix A4.1
Page 13 and 14: epresented mostly low and middle in
Page 15 and 16: was more hesitant than the younger
Page 17 and 18: a variable or to a lack of understa
Page 19 and 20: References[1] World Health Organiza
Page 21 and 22: Country FVaccine hesitancy is not a
Page 23 and 24: Figure 1. IMs’ opinions regarding
Page 25 and 26: DefinitionVaccination confidence is
Page 27 and 28: Of all participating countries, 19%
Page 29 and 30: Countries from all 3 regions provid
Page 31 and 32: Table 5: Income level of countries
Page 33 and 34: variety of determinants of vaccine
Page 35 and 36: Uruguay no no responseVenezuela no
Page 37 and 38: RussianFederationyesQuestioning dur
Page 39 and 40: Question 2:Was this % measured or e
Page 41 and 42: Of those countries which submitted
Page 43 and 44: Indicator 2:Indicator 2 was modifie
Page 45 and 46: Table 4. Top three reasons for vacc
Page 47 and 48: The overall response rate to both i
Page 49 and 50: Czech Republic No 1. The fear of si
Page 51 and 52: Kyrgyzstan Yes В 2013 году в
Page 53 and 54: Table A5.3 .1: Survey questions to
Page 55 and 56: Table A5.3.1: Survey questions to a
Page 57: Table A5.3.2: Survey questions to a
Page 61 and 62: Objective 2 - Characteristics of ev
Page 63 and 64: Most interventions targeted parents
Page 65 and 66: Table 2. PICO questions proposed by
Page 67 and 68: Dialogue-based interventionsEleven
Page 69 and 70: The impact of information-based tra
Page 71 and 72: Conclusions and implicationsLiterat
Page 73 and 74: Appendix A6A.2 Strategies to addres
Page 75 and 76: change in attitudes).- Most studies
Page 77 and 78: Strategies to address vaccine hesit
Page 79 and 80: Table 1.Summary of published litera
Page 81 and 82: Title/ First author/year of publica
Page 91 and 92: References1. Williams, S.E., What a
Page 93 and 94: Appendix A6C.1 Vaccine Hesitancy La
Page 95 and 96: ii. Google (Hong Kong)• Used the
Page 97 and 98: Categories Key Actors Areas ofWork/
Page 101 and 102: Categories Key Actors Areas ofActio
Page 107 and 108: This landscape analysis, along with
Page 109 and 110:
References for Vaccine Hesitancy La
Page 111:
67 Robert Wood Johnson Foundation.
show all

2_SAGE_Appendicies_Background_final

Create successful ePaper yourself

Delete template?

Save as template?